Published in J Rheumatol on May 01, 2000
Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis (2005) 4.67
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther (2009) 3.47
Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun (2009) 2.37
Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol (2009) 2.10
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis (2005) 2.08
Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis (2002) 1.32
TNFalpha therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis (2004) 1.29
The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford) (2010) 1.24
Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis (2011) 1.23
Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study. Ann Rheum Dis (2011) 1.19
The epidemiology of psoriatic arthritis: fact or fiction? J Rheumatol (2000) 1.16
Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) (2012) 1.15
Validation of psoriatic arthritis diagnoses in electronic medical records using natural language processing. Semin Arthritis Rheum (2010) 1.14
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One (2012) 1.12
Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies. Arthritis Care Res (Hoboken) (2010) 1.09
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis (2012) 1.08
The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord (2010) 1.07
Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis (2005) 1.07
Remission in psoriatic arthritis: is it possible and how can it be predicted? Arthritis Res Ther (2010) 1.06
Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol (2009) 1.05
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Ann Rheum Dis (2006) 1.05
Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study. PLoS One (2014) 1.02
Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann Rheum Dis (2002) 1.01
Epidemiology of spondyloarthritis. Rheum Dis Clin North Am (2012) 1.01
Epidemiology of spondyloarthritis in North America. Am J Med Sci (2011) 1.00
Update on the natural history and systemic treatment of psoriasis. Adv Dermatol (2008) 0.96
Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys. Am J Prev Med (2014) 0.96
Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med (2011) 0.95
Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis. Clin Dev Immunol (2011) 0.93
Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol (2005) 0.92
The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int (2011) 0.90
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate. Ann Rheum Dis (2006) 0.90
Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol (2010) 0.89
Dynamic magnetic resonance of the wrist in psoriatic arthritis reveals imaging patterns similar to those of rheumatoid arthritis. Arthritis Res Ther (2005) 0.88
Cardiovascular risk in patients with psoriatic arthritis. Int J Rheumatol (2012) 0.88
Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre. Int Wound J (2011) 0.87
Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative. Arthritis Res Ther (2014) 0.85
Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use. J Invest Dermatol (2015) 0.85
Introduction/overview on clinical registries. Ann Rheum Dis (2005) 0.85
Associations of psoriatic arthritis and cardiovascular conditions in a large population. Perm J (2008) 0.85
Infliximab induces increase in triglyceride levels in psoriatic arthritis patients. Clin Dev Immunol (2011) 0.84
Treating psoriatic arthritis: how effective are TNF antagonists? Arthritis Res Ther (2004) 0.83
A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis. Ann Rheum Dis (2004) 0.83
The Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am (2015) 0.83
Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity in patients with psoriatic arthritis. Arthritis Res Ther (2014) 0.82
Inflammatory polyarthritis in a patient with psoriasis: is it psoriatic arthritis or rheumatoid arthritis? Korean J Intern Med (2010) 0.81
Psoriatic arthritis: recent progress in pathophysiology and drug development. Arthritis Res Ther (2013) 0.80
The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the Rochester Epidemiology Project. Mayo Clin Proc (2013) 0.80
Infliximab (Remicade) in the treatment of psoriatic arthritis. Ther Clin Risk Manag (2006) 0.80
Prevalence of chronic axial pain, inflammatory back pain, and spondyloarthritis in diagnosed psoriasis. Arthritis Care Res (Hoboken) (2015) 0.80
Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. Arthritis Res Ther (2015) 0.79
Periodontal disease in patients with psoriatic arthritis. Inflammation (2013) 0.79
Cytokine blockers in psoriatic arthritis. Ann Rheum Dis (2001) 0.79
Cardiac manifestations of rheumatological conditions: a narrative review. ISRN Rheumatol (2012) 0.79
Developing a diagnostic checklist of traditional Chinese medicine symptoms and signs for psoriasis: a Delphi study. Chin Med (2013) 0.78
Decreased heart rate variability in patients with psoriatic arthritis. Clin Rheumatol (2012) 0.78
The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial. Lipids Health Dis (2016) 0.77
Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies. Dermatology (2016) 0.76
Secukinumab: A New Treatment Option for Psoriatic Arthritis. Rheumatol Ther (2016) 0.76
The epidemiology of psoriatic arthritis. J Rheumatol (2001) 0.75
Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide. Int J Dermatol (2016) 0.75
Is remission a more realistic goal in psoriatic arthritis? Ther Adv Musculoskelet Dis (2011) 0.75
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis. Rheumatol Ther (2014) 0.75
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial. Arthritis Care Res (Hoboken) (2015) 0.75
Heel pain due to psoriatic arthritis in a 50 year old recreational male athlete: case report. J Can Chiropr Assoc (2011) 0.75
Vitamin D status in men with psoriatic arthritis: a case-control study. Osteoporos Int (2015) 0.75
Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: A systematic literature review. Rheumatol Int (2016) 0.75
[Psoriatic arthritis]. Wien Med Wochenschr (2006) 0.75
Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study. Rheumatol Int (2017) 0.75
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49
A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19
Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int (1999) 2.83
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80
Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80
Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79
Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71
Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68
Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc (2001) 2.61
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56
The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum (1999) 2.50
Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis (2007) 2.46
Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43
Emotional responses of athletes to injury. Mayo Clin Proc (1990) 2.43
Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA (1993) 2.42
Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc (1981) 2.41
Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. Am J Psychiatry (1991) 2.38
Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol (2001) 2.36
Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science (1992) 2.36
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis (2003) 2.34
Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol (1999) 2.34
Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33
The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med (1995) 2.27
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol (1992) 2.19
Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17
Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) Neurology (1996) 2.16
Home care: the next frontier of pediatric practice. J Pediatr (1994) 2.09
Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol (1999) 2.07
The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg (1988) 2.06
Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics (1968) 2.06
Complications leading to surgery after breast implantation. N Engl J Med (1997) 2.05
Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc (1995) 2.05
Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med (1995) 2.02
Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension. Mayo Clin Proc (1991) 2.02
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Epidemiology of sarcopenia. J Am Geriatr Soc (2000) 1.97
Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab (2002) 1.96
Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res (1998) 1.93
Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology (1998) 1.92
The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol (1997) 1.91
Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol (1997) 1.91
Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol (1993) 1.91
Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc (1994) 1.89
Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthritis Rheum (1997) 1.88
Competitive athletes: preinjury and postinjury mood state and self-esteem. Mayo Clin Proc (1993) 1.87
The declining incidence of stroke. N Engl J Med (1979) 1.86
The epidemiology of venous thromboembolism in the community. Thromb Haemost (2001) 1.86
Trends in right and left-sided colon cancer. Dis Colon Rectum (1983) 1.84
Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol (1994) 1.84
Comorbidity in arthritis. J Rheumatol (1999) 1.83
Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol (2001) 1.78
Utilization of acute care services in the year before and after first stroke: A population-based study. Neurology (1996) 1.77
Bone density and fracture risk in men. J Bone Miner Res (1998) 1.77
Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol (1994) 1.75
The poor prognosis of ruptured intracranial aneurysms of the posterior circulation. J Neurosurg (1995) 1.74
Recurrent spontaneous cervical-artery dissection. N Engl J Med (1994) 1.73
Dose response studies in cotton textile workers. J Occup Med (1973) 1.73
Family adaptation to the child with cystic fibrosis. J Pediatr (1970) 1.72
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72